Mirador Capital Partners LP Sells 4,262 Shares of Cardinal Health, Inc. $CAH

Mirador Capital Partners LP decreased its stake in Cardinal Health, Inc. (NYSE:CAH) by 30.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,726 shares of the company’s stock after selling 4,262 shares during the quarter. Mirador Capital Partners LP’s holdings in Cardinal Health were worth $1,999,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Wealthcare Advisory Partners LLC grew its stake in shares of Cardinal Health by 8.8% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 2,400 shares of the company’s stock valued at $493,000 after acquiring an additional 195 shares during the period. Accurate Wealth Management LLC raised its stake in Cardinal Health by 5.9% during the 4th quarter. Accurate Wealth Management LLC now owns 5,902 shares of the company’s stock worth $1,187,000 after acquiring an additional 331 shares during the period. Net Worth Advisory Group lifted its holdings in Cardinal Health by 12.2% during the fourth quarter. Net Worth Advisory Group now owns 2,379 shares of the company’s stock valued at $489,000 after purchasing an additional 259 shares in the last quarter. Global X Japan Co. Ltd. lifted its holdings in Cardinal Health by 253.7% during the fourth quarter. Global X Japan Co. Ltd. now owns 13,710 shares of the company’s stock valued at $2,817,000 after purchasing an additional 9,834 shares in the last quarter. Finally, CoreCap Advisors LLC boosted its position in shares of Cardinal Health by 16.5% in the fourth quarter. CoreCap Advisors LLC now owns 31,333 shares of the company’s stock worth $6,439,000 after purchasing an additional 4,431 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

NYSE:CAH opened at $206.61 on Friday. The firm has a market capitalization of $48.62 billion, a price-to-earnings ratio of 29.73, a PEG ratio of 1.34 and a beta of 0.65. The business has a 50 day simple moving average of $217.41 and a 200-day simple moving average of $196.12. Cardinal Health, Inc. has a 1 year low of $120.72 and a 1 year high of $233.60.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, beating the consensus estimate of $2.31 by $0.32. The company had revenue of $65.63 billion for the quarter, compared to analyst estimates of $64.88 billion. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.Cardinal Health’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.93 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date is Wednesday, April 1st. Cardinal Health’s dividend payout ratio is presently 29.35%.

Analyst Upgrades and Downgrades

CAH has been the topic of a number of analyst reports. UBS Group set a $260.00 target price on shares of Cardinal Health and gave the company a “buy” rating in a research note on Friday, February 6th. Robert W. Baird set a $252.00 price target on Cardinal Health in a research note on Friday, February 6th. Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, January 21st. Finally, Barclays upped their price objective on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $245.67.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.